Edgewise Therapeutics

Edgewise Therapeutics company information, Employees & Contact Information

Edgewise Therapeutics, Inc., (NASDAQ: EWTX), is a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions.

Company Details

Employees
133
Founded
-
Address
1715 38th St., Boulder,co 80301,united States
Phone
720.262.7002
Email
in****@****etx.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Boulder, CO
Looking for a particular Edgewise Therapeutics employee's phone or email?

Edgewise Therapeutics Questions

News

Edgewise Therapeutics Strengthens Leadership Team to Support Late-Stage Clinical Development - Business Wire

Edgewise Therapeutics Strengthens Leadership Team to Support Late-Stage Clinical Development Business Wire

Edgewise Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference on December 3, 2024 - FinancialContent

Edgewise Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference on December 3, 2024 FinancialContent

Edgewise Provides Statement Regarding Company’s Relationship with Dr. Han Phan at Rare Disease Research - Business Wire

Edgewise Provides Statement Regarding Company’s Relationship with Dr. Han Phan at Rare Disease Research Business Wire

Edgewise Therapeutics to Participate at Evercore ISI 4th Annual HEALTHCONx Conference on December 2 - FinancialContent

Edgewise Therapeutics to Participate at Evercore ISI 4th Annual HEALTHCONx Conference on December 2 FinancialContent

Edgewise Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights - Business Wire

Edgewise Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights Business Wire

Edgewise Therapeutics to Participate at SVB Leerink 11th Annual Global Healthcare Conference on February 16 - FinancialContent

Edgewise Therapeutics to Participate at SVB Leerink 11th Annual Global Healthcare Conference on February 16 FinancialContent

Edgewise Therapeutics to Present on Sevasemten for the Treatment of Becker Muscular Dystrophy at the 2025 MDA Clinical and Scientific Conference - Business Wire

Edgewise Therapeutics to Present on Sevasemten for the Treatment of Becker Muscular Dystrophy at the 2025 MDA Clinical and Scientific Conference Business Wire

Edgewise Therapeutics Reports Second Quarter 2021 Financial Results - FinancialContent

Edgewise Therapeutics Reports Second Quarter 2021 Financial Results FinancialContent

Edgewise Therapeutics to Participate at SVB Leerink CybeRx Series: Neuromuscular, Rare Diseases & Genetic Medicines 1x1 Event on September 23 - FinancialContent

Edgewise Therapeutics to Participate at SVB Leerink CybeRx Series: Neuromuscular, Rare Diseases & Genetic Medicines 1x1 Event on September 23 FinancialContent

Top Edgewise Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant